Organon & Co. ( OGN) - Stock Earnings
OGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 160.0 million USD | 1.6 billion USD |
| 2025Q4 | -205.0 million USD | 1.5 billion USD |
| 2026Q1 | 146.0 million USD | 1.5 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
OGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.0 billion USD | 6.3 billion USD |
| 2024 | 864.0 million USD | 6.4 billion USD |
| 2025 | 187.0 million USD | 6.2 billion USD |
| 2026 Est. | — | — |
OGN
Price: $13.40
Dividend Yield: 0.60%
Forward Dividend Yield: 0.60%
Payout Ratio: 28.87%
Dividend Per Share: 0.08 USD
Earnings Per Share: 0.93 USD
P/E Ratio: 14.31
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 1.6 million
Market Capitalization: 3.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 6
DGR3: -7.74%